One Shot™ BL21(DE3) Chemically Competent E. coli
해당 제품을 구매한 고객들이 함께 검색한 제품을 추천해드립니다. 온라인 할인 진행 중!
본 제품은 LMO 제품으로, 고객 분께서 LMO 신고 시스템을 통해 직접 수입 신고를 진행해주셔야 합니다. 자세히보기
One Shot&trade; BL21(DE3) Chemically Competent <i>E. coli</i>
Invitrogen™

One Shot™ BL21(DE3) Chemically Competent E. coli

BL21(DE3) E. coli 는 bacteriophage T7 promoter 기반 발현 시스템(예, pRSET, pCR¤T7, pET)에 사용하기 이상적입니다. BL21(DE3)에는 lambda DE3 lysogen이 들어있습니다.자세히 알아보기
Have Questions?
카탈로그 번호수량
C60000321 x 50 μL/tube
카탈로그 번호 C600003
제품 가격(KRW)
485,000
온라인 행사
Ends: 31-Dec-2025
538,000
할인액 53,000 (10%)
Each
카트에 추가하기
수량:
21 x 50 μL/tube
제품 가격(KRW)
485,000
온라인 행사
Ends: 31-Dec-2025
538,000
할인액 53,000 (10%)
Each
카트에 추가하기
BL21(DE3) E. coli 는 bacteriophage T7 promoter 기반 발현 시스템(, pRSET, pCR¤T7, pET)에 사용하기 이상적입니다. BL21(DE3)에는 lambda DE3 lysogen이 들어있습니다. E. coli 에 비독성인 재조합 단백질은 대개 BL21(DE3)pLysS 또는 BL21(DE3)pLysE에서보다 BL21(DE3) 세포에서 높게 발현됩니다. 하지만 heterologous 유전자의 기본 발현 수준이 BL21(DE3)pLysS 또는 BL21(DE3)pLysE보다 BL21(DE3)에서 유의하게 높습니다.
For Research Use Only. Not for use in diagnostic procedures.
사양
항생제 내성 박테리아No
블루/화이트 스크리닝No
메틸화 DNA 클로닝No
에프에피솜 포함No
고처리량 호환성Low
플라스미드 품질 개선No
Improves Protein StabilityYes (lon, ompT)
Improves RNA StabilityNo
비메틸화 DNA 준비Yes (dcm)
제품라인One Shot
제품 유형Chemically Competent Cells
수량21 x 50 μL/tube
재조합 감소No
배송 조건Dry Ice
T1 Phage - 저항성(tonA)No
Toxic ProteinsNo
형질전환 효율 수준Medium Efficiency (1 x 108 to 1 x 109 cfu/μg)
형식Tube
프로모터T7
E. coli (B)
Unit SizeEach
구성 및 보관
• One Shot BL21(DE3) Chemically Competent E.coli (21 x 50 μL); store at –80°C
• pUC19 DNA (1 x 50 μL); store at –20°C
• S.O.C. Medium (6 mL); store at 4°C or room temperature

자주 묻는 질문(FAQ)

My gene of interest is toxic to bacterial cells. Are there any precautions you can suggest?

Several precautions may be taken to prevent problems resulting from basal level expression of a toxic gene of interest. These methods all assume that the T7-based or Champion-based expression plasmid has been correctly designed and created.

- Propagate and maintain your expression plasmid in a strain that does not contain T7 RNA polymerase (i.e., DH5α).
- If using BL21 (DE3) cells, try growing cells at room temperature rather than 37 degrees C for 24-48 hr.
- Perform a fresh transformation using a tightly regulated E. coli strain, such as BL21-AI cells.
- After following the transformation protocol, plate the transformation reaction on LB plates containing 100 µg/mL ampicillin and 0.1% glucose. The presence of glucose represses basal expression of T7 RNA polymerase.
- Following transformation of BL21-AI cells, pick 3 or 4 transformants and inoculate directly into fresh LB medium containing 100 µg/mL ampicillin or 50 µg/mL carbenicillin (and 0.1% glucose, if desired). When the culture reaches an OD600 of 0.4, induce expression of the recombinant protein by adding L-arabinose to a final concentration of 0.2%.
- When performing expression experiments, supplement the growth medium with 0.1% glucose in addition to 0.2% arabinose.
- Try a regulated bacterial expression system such as our pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm trying to express my protein using a bacterial expression system. How do I know if I'm seeing degradation of my protein or if what I’m seeing is codon usage bias?

Typically, if you see 1-2 dominant bands, translation stopped prematurely due to codon usage bias. With degradation, you usually see a ladder of bands. With degradation, you can try using a protease inhibitor and add it to the lysis buffer to help prevent degradation. If degradation is the issue, a time point experiment can be done to determine the best time to harvest the cells.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm trying to express my protein using a bacterial expression system and am getting inclusion bodies. What should I do?

If you are having a solubility issue, try to decrease the temperature or decrease the amount of IPTG used for induction. You can also try a different, more stringent cell strain for expression. Adding 1% glucose to the bacterial culture medium during expression can also help.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

I'm getting low protein yield from my bacterial expression system. What can I do to improve this?

- Inoculate from fresh bacterial cultures, since higher protein yields are generally obtained from a fresh bacterial colony.

- Check the codon usage in the recombinant protein sequence for infrequently used codons. Replacing the rare codons with more commonly used codons can significantly increase expression levels. For example, the arginine codons AGG and AGA are used infrequently by E. coli, so the level of tRNAs for these codons is low.

- Add protease inhibitors, such as PMSF, to buffers during protein purification. Use freshly made PMSF, since PMSF loses effectiveness within 30 min of dilution into an aqueous solution.

- If you are using ampicillin for selection in your expression experiments, you may be experiencing plasmid instability due to the absence of selective conditions. This occurs as the ampicillin is destroyed by β-lactamase or hydrolyzed under the acidic media conditions generated by bacterial metabolism. You may want to substitute carbenicillin for ampicillin in your transformation and expression experiments.

- The recombinant protein may be toxic to bacterial cells. Try a tighter regulation system for competent cell expression such as BL21-AI. You may also consider trying a different expression system such as the pBAD system.

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

My cells are growing very slowly, and I'm not getting any protein expression from my baterial expression system. What can I do to fix this?

This typically occurs when your gene of interest is toxic. Try using a tighter regulation system, such as BL21 (DE3) (pLysS) or BL21 (DE3) (pLysE), or BL21(AI).

Find additional tips, troubleshooting help, and resources within our Protein Expression Support Center.

인용 및 참조 문헌 (12)

인용 및 참조 문헌
Abstract
The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly.
Authors:Javanbakht H, Halwani R, Cen S, Saadatmand J, Musier-Forsyth K, Gottlinger H, Kleiman L,
Journal:J Biol Chem
PubMed ID:12756246
'Human lysyl-tRNA synthetase (LysRS) is a tRNA-binding protein that is selectively packaged into HIV-1 along with its cognate tRNALys isoacceptors. Evidence exists that Gag alone is sufficient for the incorporation of LysRS into virions. Herein, using both in vitro and in vivo methods, we begin to map regions in Gag ... More
The anti-trp RNA-binding attenuation protein (Anti-TRAP), AT, recognizes the tryptophan-activated RNA binding domain of the TRAP regulatory protein.
Authors: Valbuzzi Angela; Gollnick Paul; Babitzke Paul; Yanofsky Charles;
Journal:J Biol Chem
PubMed ID:11786553
'In Bacillus subtilis, the trp RNA-binding attenuation protein (TRAP) regulates expression of genes involved in tryptophan metabolism in response to the accumulation of l-tryptophan. Tryptophan-activated TRAP negatively regulates expression by binding to specific mRNA sequences and either promoting transcription termination or blocking translation initiation. Conversely, the accumulation of uncharged tRNA(Trp) ... More
The ISG15 isopeptidase UBP43 is regulated by proteolysis via the SCFSkp2 ubiquitin ligase.
Authors:Tokarz S, Berset C, La Rue J, Friedman K, Nakayama K, Nakayama K, Zhang DE, Lanker S,
Journal:J Biol Chem
PubMed ID:15342634
'The Skp2 oncoprotein belongs to the family of F-box proteins that function as substrate recognition factors for SCF (Skp1, cullin, F-box protein) E3 ubiquitin-ligase complexes. Binding of the substrate to the SCFSkp2 complex catalyzes the conjugation of ubiquitin molecules to the bound substrate, resulting in multi-ubiquitination and rapid degradation by ... More
A proteolytic transmembrane signaling pathway and resistance to beta-lactams in staphylococci.
Authors:Zhang HZ, Hackbarth CJ, Chansky KM, Chambers HF.
Journal:Science
PubMed ID:11239156
beta-Lactamase and penicillin-binding protein 2a mediate staphylococcal resistance to beta-lactam antibiotics, which are otherwise highly clinically effective. Production of these inducible proteins is regulated by a signal-transducing integral membrane protein and a transcriptional repressor. The signal transducer is a fusion protein with penicillin-binding and zinc metalloprotease domains. The signal for ... More
The solution structure and interactions of CheW from Thermotoga maritima.
Authors: Griswold Ian J; Zhou Hongjun; Matison Mikenzie; Swanson Ronald V; McIntosh Lawrence P; Simon Melvin I; Dahlquist Frederick W;
Journal:Nat Struct Biol
PubMed ID:11799399
Using protein from the hyperthermophile Thermotoga maritima, we have determined the solution structure of CheW, an essential component in the formation of the bacterial chemotaxis signaling complex. The overall fold is similar to the regulatory domain of the chemotaxis kinase CheA. In addition, interactions of CheW with CheA were monitored ... More